rs3752433

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000444.6(PHEX):​c.1769-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 1,189,912 control chromosomes in the GnomAD database, including 39,137 homozygotes. There are 109,873 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 4773 hom., 10316 hem., cov: 22)
Exomes 𝑓: 0.29 ( 34364 hom. 99557 hem. )

Consequence

PHEX
NM_000444.6 intron

Scores

2
Splicing: ADA: 0.00003442
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0920

Publications

12 publications found
Variant links:
Genes affected
PHEX (HGNC:8918): (phosphate regulating endopeptidase X-linked) The protein encoded by this gene is a transmembrane endopeptidase that belongs to the type II integral membrane zinc-dependent endopeptidase family. The protein is thought to be involved in bone and dentin mineralization and renal phosphate reabsorption. Mutations in this gene cause X-linked hypophosphatemic rickets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
PTCHD1-AS (HGNC:37703): (PTCHD1 antisense RNA (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-22221603-C-T is Benign according to our data. Variant chrX-22221603-C-T is described in ClinVar as Benign. ClinVar VariationId is 256167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.443 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHEXNM_000444.6 linkc.1769-10C>T intron_variant Intron 17 of 21 ENST00000379374.5 NP_000435.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHEXENST00000379374.5 linkc.1769-10C>T intron_variant Intron 17 of 21 1 NM_000444.6 ENSP00000368682.4

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
36569
AN:
110633
Hom.:
4767
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.449
Gnomad AMI
AF:
0.437
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.251
Gnomad EAS
AF:
0.159
Gnomad SAS
AF:
0.189
Gnomad FIN
AF:
0.315
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.309
Gnomad OTH
AF:
0.319
GnomAD2 exomes
AF:
0.264
AC:
47963
AN:
181989
AF XY:
0.260
show subpopulations
Gnomad AFR exome
AF:
0.454
Gnomad AMR exome
AF:
0.124
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.170
Gnomad FIN exome
AF:
0.319
Gnomad NFE exome
AF:
0.307
Gnomad OTH exome
AF:
0.291
GnomAD4 exome
AF:
0.295
AC:
317906
AN:
1079225
Hom.:
34364
Cov.:
27
AF XY:
0.285
AC XY:
99557
AN XY:
349525
show subpopulations
African (AFR)
AF:
0.468
AC:
12144
AN:
25973
American (AMR)
AF:
0.135
AC:
4738
AN:
35129
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
4517
AN:
19268
East Asian (EAS)
AF:
0.163
AC:
4891
AN:
30089
South Asian (SAS)
AF:
0.180
AC:
9696
AN:
53756
European-Finnish (FIN)
AF:
0.324
AC:
13097
AN:
40445
Middle Eastern (MID)
AF:
0.302
AC:
1201
AN:
3974
European-Non Finnish (NFE)
AF:
0.308
AC:
254196
AN:
825199
Other (OTH)
AF:
0.296
AC:
13426
AN:
45392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
6738
13477
20215
26954
33692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8708
17416
26124
34832
43540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.331
AC:
36603
AN:
110687
Hom.:
4773
Cov.:
22
AF XY:
0.313
AC XY:
10316
AN XY:
32977
show subpopulations
African (AFR)
AF:
0.449
AC:
13629
AN:
30366
American (AMR)
AF:
0.215
AC:
2252
AN:
10479
Ashkenazi Jewish (ASJ)
AF:
0.251
AC:
660
AN:
2625
East Asian (EAS)
AF:
0.159
AC:
562
AN:
3527
South Asian (SAS)
AF:
0.191
AC:
506
AN:
2651
European-Finnish (FIN)
AF:
0.315
AC:
1830
AN:
5817
Middle Eastern (MID)
AF:
0.362
AC:
76
AN:
210
European-Non Finnish (NFE)
AF:
0.309
AC:
16317
AN:
52837
Other (OTH)
AF:
0.317
AC:
476
AN:
1500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
891
1783
2674
3566
4457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.307
Hom.:
18702
Bravo
AF:
0.330

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1769-10C>T in intron 17 of PHEX: This variant is not expected to have clinical significance because a C>T change at this position does not diverge from the sp lice consensus sequence and is therefore unlikely to impact splicing. It has bee n identified in 44.62% (3722/8342) of African chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3752433). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial X-linked hypophosphatemic vitamin D refractory rickets Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.8
DANN
Benign
0.61
PhyloP100
0.092
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000034
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3752433; hg19: chrX-22239720; COSMIC: COSV65079356; API